Cargando…

Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy

INTRODUCTION: The gut microbiota (GM) can influence the pathogenesis of immune‐mediated adverse events (irAEs). Proton pump inhibitors (PPIs) can affect the integrity of GM, but their role in promoting irAEs is still poorly understood. METHODS: In this retrospective single‐center cohort study, the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasagna, Angioletta, Mascaro, Federica, Figini, Simone, Basile, Sara, Gambini, Giulia, Klersy, Catherine, Lenti, Marco Vincenzo, Di Sabatino, Antonio, Di Benedetto, Alice, Calvi, Monica, Bruno, Raffaele, Sacchi, Paolo, Pedrazzoli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637049/ https://www.ncbi.nlm.nih.gov/pubmed/37737046 http://dx.doi.org/10.1002/cam4.6565

Ejemplares similares

Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research
por: Lasagna, Angioletta, et al.
Publicado: (2021)

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
por: Lasagna, Angioletta, et al.
Publicado: (2022)

COVID-19 and breast cancer: may the microbiome be the issue?
por: Lasagna, Angioletta, et al.
Publicado: (2020)

The Role of Pre-treatment Inflammatory Biomarkers in the Prediction of an Early Response to Panitumumab in Metastatic Colorectal Cancer
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma
por: Serra, Francesco, et al.
Publicado: (2021)

The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Vaccine Immunotherapy for Celiac Disease
por: Di Sabatino, Antonio, et al.
Publicado: (2018)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

In reply to: “A COVID-19 screening tool for oncology telephone triage”
por: Lasagna, Angioletta, et al.
Publicado: (2020)

Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study
por: Asperges, Erika, et al.
Publicado: (2023)

Evaluation of diagnostic time in pediatric patients with eosinophilic gastrointestinal disorders according to their clinical features
por: Votto, Martina, et al.
Publicado: (2023)

Serum Markers of Refractoriness and Enteropathy-Associated T-Cell Lymphoma in Coeliac Disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
por: Tsuda, Ayumi, et al.
Publicado: (2015)

Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma
por: Okuyama, Yoshiharu, et al.
Publicado: (2021)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Gastrointestinal adverse events of immunotherapy
por: Cappello, Giovanni, et al.
Publicado: (2021)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

COVID-19-related symptom clustering in a primary care vs internal medicine setting
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Determinants of COVID-19-related mortality in an internal medicine setting
por: Lenti, Marco Vincenzo, et al.
Publicado: (2022)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019)

Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications
por: Rossi, Carlo Maria, et al.
Publicado: (2022)

Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease
por: Giuffrida, Paolo, et al.
Publicado: (2019)

Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis
por: Cardoso, Rhanderson N, et al.
Publicado: (2015)

A Study of Proton Pump Inhibitors and Other Risk Factors in Warfarin-Associated Gastrointestinal Bleeding
por: Tang, Jevon, et al.
Publicado: (2021)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

Immunotherapy with Pru p 3 for food allergy to peach and non-specific lipid transfer protein: a systematic review
por: Rossi, Carlo Maria, et al.
Publicado: (2023)

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
por: Pedrazzoli, P., et al.
Publicado: (2023)

A young man with persistent dyspepsia: the unexpected virtue of proton-pump inhibitors
por: Paolo, Fraticelli, et al.
Publicado: (2018)

Resilience is associated with frailty and older age in hospitalised patients
por: Lenti, Marco Vincenzo, et al.
Publicado: (2022)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Progress with proton pump inhibition.
por: Bell, N. J., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_jnelbov97rh430lpl1k1rsp02h